Pharmaceuticals · Key players

Top Rheumatoid Arthritis Drugs companies

The 6 key players our Rheumatoid Arthritis Drugs report profiles, and other companies free public records show in this market.

Key players in Rheumatoid Arthritis Drugs

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Key players in the Rheumatoid Arthritis Drugs market
#CompanyWebsiteOur reports
1 AbbVie Inc. abbvie.com (opens in a new tab) 1,254 reports
2 Pfizer Inc. pfizer.com (opens in a new tab) 2,310 reports
3 Johnson & Johnson jnj.com (opens in a new tab) 2,376 reports
4 Roche roche.com (opens in a new tab) 1,485 reports
5 Bristol-Myers Squibb bms.com (opens in a new tab) 627 reports
6 Eli Lilly and Company lilly.com (opens in a new tab) 1,056 reports

Also active in Rheumatoid Arthritis Drugs

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Also active in Rheumatoid Arthritis Drugs, from free public records
CompanyWhere public records show them
Amneal Pharmaceuticals, Inc
Zimmer Biomet Holdings, Inc.
Hikma Pharmaceuticals PLC
Aurobindo Pharma
Medacta International SA
Novartis AG
Zydus Lifesciences
Dr Reddy’s Laboratories
MicroPort Scientific Corporation
Novitium Pharma
Aesculap AG
Fresenius SE & CO

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.

Top trial sponsors in Rheumatoid Arthritis Drugs

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. Zimmer Biomet Holdings, Inc. 21 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Bristol-Myers Squibb 10 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Medacta International SA 9 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Novartis AG 9 active trials on ClinicalTrials.gov (opens in a new tab)
  5. MicroPort Scientific Corporation 8 active trials on ClinicalTrials.gov (opens in a new tab)
  6. AbbVie Inc. 6 active trials on ClinicalTrials.gov (opens in a new tab)
  7. Aesculap AG 5 active trials on ClinicalTrials.gov (opens in a new tab)
  8. AstraZeneca 4 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Rheumatoid Arthritis Drugs reports by place

One report for each place. Each tile opens that place's report.

Regions 7

World report Africa report APAC report Europe report Latin America report Middle East report North America report

Countries 26

Australia report Brazil report Canada report China report Ecuador report Egypt report France report Germany report Hong Kong report India report Italy report Japan report Kenya report Malaysia report Mexico report New Zealand report Philippines report Russia report Saudi Arabia report Singapore report South Africa report Spain report Thailand report UAE report UK report US report

Compare all 33 places for Rheumatoid Arthritis Drugs, with active trials

Get the full Rheumatoid Arthritis Drugs report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Buy the full report Request free sample

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.